Literature DB >> 12495640

Chemokine biology in cancer.

Fran Balkwill1.   

Abstract

Many human cancers possess a complex chemokine network that may influence the extent and phenotype of the leukocyte infiltrate, angiogenesis, tumor cell growth, survival and migration. Restricted expression of chemokine receptors on leukocytes may allow concise control of cell movement and retention at the tumor site. Restricted and specific expression of chemokine receptors on tumor cells may be involved in the characteristic patterns of metastasis, and may promote tumor cell growth and survival. Detailed study of chemokine and chemokine receptor antagonists in experimental cancer models is warranted. Manipulation of the tumor chemokine network could have therapeutic potential in malignant disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12495640     DOI: 10.1016/s1044-5323(02)00127-6

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  72 in total

Review 1.  Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.

Authors:  Jian Zhang; Lalit Patel; Kenneth J Pienta
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

Review 2.  Chemokines in tumor angiogenesis and metastasis.

Authors:  Seema Singh; Anguraj Sadanandam; Rakesh K Singh
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

3.  CXCL12 G801A polymorphism and breast cancer risk: a meta-analysis.

Authors:  Weisheng Shen; Xiangming Cao; Lei Xi; Lichun Deng
Journal:  Mol Biol Rep       Date:  2011-06-05       Impact factor: 2.316

4.  Epithelial tumor, invasion and stroma.

Authors:  Masutaka Furue
Journal:  Ann Dermatol       Date:  2011-05-27       Impact factor: 1.444

5.  Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma.

Authors:  Feng Lin; Shui-er Zheng; Zan Shen; Li-na Tang; Ping Chen; Yuan-jue Sun; Hui Zhao; Yang Yao
Journal:  Med Oncol       Date:  2010-03-27       Impact factor: 3.064

Review 6.  CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis.

Authors:  Jian Zhang; Lalit Patel; Kenneth J Pienta
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-14       Impact factor: 7.638

Review 7.  Altered macrophage differentiation and immune dysfunction in tumor development.

Authors:  Antonio Sica; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

8.  SPARC ameliorates ovarian cancer-associated inflammation.

Authors:  Neveen A Said; Ahmed A Elmarakby; John D Imig; David J Fulton; Kouros Motamed
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

9.  SDF-1 and CCR5 genes polymorphism in patients with head and neck cancer.

Authors:  Bijan Khademi; Mahboobeh Razmkhah; Nasrollah Erfani; Marjan Gharagozloo; Abbas Ghaderi
Journal:  Pathol Oncol Res       Date:  2008-04-02       Impact factor: 3.201

10.  SDF1-3' a gene polymorphism is associated with laryngeal cancer.

Authors:  Lukasz Kruszyna; Margarita Lianeri; Małgorzata Rydzanicz; Krzysztof Szyfter; Paweł P Jagodziński
Journal:  Pathol Oncol Res       Date:  2009-10-16       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.